The Premier Inc (PINC) share price is expected to increase by 1.62% over the next year. This is based on calculating the average 12-month share price estimate provided by 12 stock analysts who have covered PINC. Price targets range from $18 at the low end to $21 at the high end. The current analyst consensus for PINC is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
PINC is a stock in Healthcare which has been forecasted to be worth $19.5 as an average. On the higher end, the forecast price is $21 USD by Anne Samuel from JP Morgan and on the lower end PINC is forecasted to be $18 by from .
These are the latest 20 analyst ratings of PINC.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Richard Close Canaccord Genuity | Hold | $19 | Maintains | Oct 2, 2024 |
Anne Samuel JP Morgan | Neutral | $19 | Maintains | Sep 9, 2024 |
Bill Sutherland Benchmark | Hold | Downgrade | Aug 26, 2024 | |
Eric Coldwell Baird | Neutral | $19 | Maintains | Aug 21, 2024 |
Richard Close Canaccord Genuity | Hold | $20 | Maintains | Aug 21, 2024 |
Anne Samuel JP Morgan | Neutral | $21 | Maintains | May 28, 2024 |
Eric Coldwell Baird | Neutral | $22 | Maintains | May 8, 2024 |
Richard Close Canaccord Genuity | Hold | $21 | Downgrade | May 8, 2024 |
Jessica Tassan Piper Sandler | Neutral | $22 | Maintains | May 8, 2024 |
Michael Cherny Leerink Partners | Market Perform | $22.5 | Initiates | Feb 26, 2024 |
Anne Samuel JP Morgan | Neutral | $21 | Maintains | Nov 13, 2023 |
Bill Sutherland Benchmark | Buy | $30 | Maintains | Nov 9, 2023 |
Jonathan Yong Credit Suisse | Neutral | $25 | Maintains | Aug 24, 2023 |
Eric Coldwell Baird | Neutral | $24 | Maintains | Aug 24, 2023 |
Richard Close Canaccord Genuity | Buy | $30 | Maintains | Aug 23, 2023 |
Bill Sutherland Benchmark | Buy | $32 | Maintains | Aug 23, 2023 |
Jessica Tassan Piper Sandler | Neutral | $25 | Downgrade | Aug 23, 2023 |
Michael Cherny B of A Securities | Underperform | $26 | Maintains | Aug 23, 2023 |
Kevin Caliendo UBS | Neutral | $26 | Maintains | Aug 23, 2023 |
Bill Sutherland Benchmark | Buy | $37 | Reiterates | Jun 15, 2023 |
When did it IPO
2013
Staff Count
2,900
Country
United States
Sector/Industry
Healthcare/Health Information Services
CEO
Mr. Michael J. Alkire
Market Cap
$1.93B
In 2023, PINC generated $1.34B in revenue, which was a decrease of -6.76% from the previous year. This can be seen as a signal that PINC's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Premier Inc. (NASDAQ:PINC) held its Q4 2024 earnings conference call on August 20, 2024, featuring key executives and analysts from various financial institutions.
Why It Matters - The Premier Inc. earnings call signals financial updates and strategic insights, crucial for assessing performance and future growth, directly influencing stock valuation and investor sentiment.
Summary - Premier, Inc. (NASDAQ: PINC) reported its fiscal 2024 Q4 and full-year results, thanking employees for their commitment to supporting healthcare providers. Further financial details were not disclosed.
Why It Matters - Premier, Inc.'s financial results may indicate growth or challenges in the healthcare sector, influencing stock performance and investor sentiment in technology-driven healthcare firms.
Summary - Premier, Inc. (PINC) reported Q3 earnings of $0.69 per share, surpassing the Zacks Consensus Estimate of $0.49. This reflects a slight increase from $0.68 per share year-over-year.
Why It Matters - Premier, Inc.'s earnings beat expectations, indicating strong performance and potential growth, which can enhance investor confidence and positively influence stock valuation.
Summary - Premier (PINC) reported its revenue and EPS for Q2 2024, which should be analyzed in relation to Wall Street estimates and year-over-year performance for a comprehensive understanding.
Why It Matters - Comparing Premier's revenue and EPS with Wall Street estimates and prior year figures reveals trends in growth, profitability, and market expectations, influencing investment decisions and stock valuation.
Summary - Coleman has been appointed as Chief Administrative and Financial Officer of Premier, effective November 11, 2024.
Why It Matters - Coleman's appointment as CFO may signal strategic changes in financial management, impacting investor confidence and potentially influencing stock performance.
Summary - Delphinus Medical Technologies secured a national group purchasing agreement and Technology Breakthrough designation from Premier, Inc. for its SoftVueโข Breast Ultrasound Tomography, offering special pricing to members.
Why It Matters - Delphinus Medical's new agreement with Premier could boost sales and market presence, enhancing revenue potential and investor confidence in its growth trajectory.